BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31931472)

  • 21. Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of
    Loiben AM; Chien WM; Friedman CE; Chao LS; Weber G; Goldstein A; Sniadecki NJ; Murry CE; Yang KC
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation of the MYH7 gene in a patient with hypertrophic cardiomyopathy.
    Goel N; Huddleston CB; Fiore AC
    Turk J Pediatr; 2018; 60(3):315-318. PubMed ID: 30511546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction.
    Kinnear C; Said A; Meng G; Zhao Y; Wang EY; Rafatian N; Parmar N; Wei W; Billia F; Simmons CA; Radisic M; Ellis J; Mital S
    Cell Rep Med; 2024 May; 5(5):101520. PubMed ID: 38642550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
    Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
    PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.
    Bhagwan JR; Mosqueira D; Chairez-Cantu K; Mannhardt I; Bodbin SE; Bakar M; Smith JGW; Denning C
    J Mol Cell Cardiol; 2020 Aug; 145():43-53. PubMed ID: 32531470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
    Han L; Li Y; Tchao J; Kaplan AD; Lin B; Li Y; Mich-Basso J; Lis A; Hassan N; London B; Bett GC; Tobita K; Rasmusson RL; Yang L
    Cardiovasc Res; 2014 Nov; 104(2):258-69. PubMed ID: 25209314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertrophic cardiomyopathy
    Rose J; Kraft T; Brenner B; Montag J
    Physiol Genomics; 2020 Jan; 52(1):15-19. PubMed ID: 31790337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Dias GM; Lamounier Júnior A; Seifert M; Barájas-Martinez H; Barr D; Sternick EB; Medina-Acosta E; Campos de Carvalho AC; Cruz Filho FES
    Circ Genom Precis Med; 2021 Oct; 14(5):e003476. PubMed ID: 34555931
    [No Abstract]   [Full Text] [Related]  

  • 30. A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations.
    Cohn R; Thakar K; Lowe A; Ladha FA; Pettinato AM; Romano R; Meredith E; Chen YS; Atamanuk K; Huey BD; Hinson JT
    Stem Cell Reports; 2019 Jan; 12(1):71-83. PubMed ID: 30554920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs.
    Montag J; Petersen B; Flögel AK; Becker E; Lucas-Hahn A; Cost GJ; Mühlfeld C; Kraft T; Niemann H; Brenner B
    Sci Rep; 2018 Mar; 8(1):4786. PubMed ID: 29555974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
    Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
    Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations].
    Zhao J; Wang J; Liu LW; Zheng Y; Wang B; Li WX; Yang F; Kang N; Zuo L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):287-293. PubMed ID: 32370479
    [No Abstract]   [Full Text] [Related]  

  • 35. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Hämäläinen L; Melin J; Kärkkäinen S; Peuhkurinen K; Nieminen MS; Laakso M; ; Kuusisto J
    Ann Med; 2014 Sep; 46(6):424-9. PubMed ID: 24888384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsic MYH7 expression regulation contributes to tissue level allelic imbalance in hypertrophic cardiomyopathy.
    Montag J; Syring M; Rose J; Weber AL; Ernstberger P; Mayer AK; Becker E; Keyser B; Dos Remedios C; Perrot A; van der Velden J; Francino A; Navarro-Lopez F; Ho CY; Brenner B; Kraft T
    J Muscle Res Cell Motil; 2017 Aug; 38(3-4):291-302. PubMed ID: 29101517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of genotype and phenotype correlation of MYH7-V878A mutation among ethnic Han Chinese pedigrees affected with hypertrophic cardiomyopathy].
    Wang B; Guo R; Zuo L; Shao H; Liu Y; Wang Y; Ju Y; Sun C; Wang L; Zhang Y; Liu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):514-518. PubMed ID: 28777849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells.
    Lan F; Lee AS; Liang P; Sanchez-Freire V; Nguyen PK; Wang L; Han L; Yen M; Wang Y; Sun N; Abilez OJ; Hu S; Ebert AD; Navarrete EG; Simmons CS; Wheeler M; Pruitt B; Lewis R; Yamaguchi Y; Ashley EA; Bers DM; Robbins RC; Longaker MT; Wu JC
    Cell Stem Cell; 2013 Jan; 12(1):101-13. PubMed ID: 23290139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertrophic cardiomyopathy: New pathogenic variant in MYH7.
    Vargas-Ursúa F; Melendo-Viu M; Íñiguez-Romo A
    Med Clin (Barc); 2024 Jun; 162(11):563-564. PubMed ID: 38423942
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.